1. Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trial. Issue 4 (October 2016) Authors: van Raalte, Daniël H; Bunck, Mathijs C; Smits, Mark M; Hoekstra, T; Cornér, Anja; Diamant, Michaela; Eliasson, Bjorn; Marja-RiittaTaskinen, ; Heine, Robert J; Smith, Ulf; HanneleYki-Järvinen, ; Mari, Andrea Journal: European journal of endocrinology Issue: Volume 175:Issue 4(2016) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗